Jill Wechsler, Pharm Exec's Washington Correspondent

President Joe Biden has unveiled a lengthy program for combatting COVID-19 by ramping up distribution and inoculation of millions of Americans over the next three months.

The process of distributing millions of doses of new vaccines across the nation has been much less effective than anticipated.

Administration officials continue to rush through new rules and decisions that appear to challenge the independence and effective operations of FDA.

Biden administration faces key decisions on drug testing and access amid vaccine distribution challenges.